Management of MAOI-Induced Diarrhea

Initial Management Approach

The American Society of Clinical Oncology recommends implementing dietary modifications by eliminating lactose-containing products, alcohol, and high-osmolar supplements, and encouraging consumption of 8-10 large glasses of clear liquids daily, and recommending frequent small meals consisting of low-residue foods 3, 4
Monitoring and recording the number of stools and reporting any symptoms of life-threatening sequelae, such as fever or dizziness upon standing, is crucial 3

The American College of Gastroenterology recommends starting loperamide at an initial dose of 4 mg followed by 2 mg every 2-4 hours or after every unformed stool, with a maximum daily dose of 16 mg 1, 2
Loperamide should be continued until 12 hours after diarrhea resolves, as recommended by the Journal of Clinical Oncology 3, 4

Increasing the loperamide dose to 2 mg every 2 hours may be necessary for persistent diarrhea, according to the Journal of Clinical Oncology 3, 5
Considering oral antibiotics as prophylaxis for infection if risk factors are present is also recommended 3, 6

Discontinuing loperamide and switching to second-line agents, such as octreotide or oral budesonide, may be necessary for refractory diarrhea, as recommended by the American Society of Clinical Oncology 1, 2
Octreotide can be administered subcutaneously at a dose of 100-150 μg three times a day, which can be titrated up to 500 μg three times a day 1, 2

Administering intravenous fluids to correct dehydration is essential, as recommended by the American College of Gastroenterology 1, 2
Considering octreotide IV at a dose of 25-50 μg/hr if severe dehydration is present is also recommended 3, 4

Bile acid sequestrants, such as cholestyramine or colestipol, may be effective adjuvant therapies for bile salt malabsorption, which may contribute to MAOI-induced diarrhea, according to the American Gastroenterological Association 1, 7
Avoiding spices, coffee, and foods with insoluble fiber is recommended to help manage MAOI-induced diarrhea, as suggested by the American Society of Clinical Oncology 1, 2

Evaluating for other causes of diarrhea, especially if symptoms are severe or persistent despite appropriate management, is crucial, as recommended by the Journal of Clinical Oncology 3, 8
Being vigilant for signs of dehydration or electrolyte imbalances, which require prompt intervention, is essential, according to the American College of Gastroenterology 1, 2